Docusign, INC Form 4 insider transactions

DocuSign's Chief Legal Officer, James P. Shaughnessy, sold a total of 7,500 shares of common stock on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

DocuSign's CEO, Allan Thygesen, sold a total of 40,000 shares of common stock on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

A DocuSign executive, Robert Chatwani, sold 14,800 shares of common stock at an average price of $97.76, under a pre-arranged 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 15,588 shares of common stock on December 18, 2024, under a pre-arranged 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold shares of the company's stock following the vesting of restricted stock units.

Director Daniel D. Springer of DocuSign, Inc. reported the acquisition of 2,182 shares and the disposal of 332 shares of common stock on December 15, 2024, along with the vesting of 2,182 restricted stock units.

A DocuSign director, Teresa Briggs, sold 534 shares of common stock at $94.60 per share on December 16, 2024, under a pre-arranged 10b5-1 trading plan.

DocuSign's Chief Legal Officer, James P. Shaughnessy, reported the vesting and tax withholding of restricted stock units and performance stock units.

DocuSign's CEO, Allan Thygesen, engaged in stock transactions involving the vesting and tax withholding of restricted stock units and performance stock units.

DocuSign's President and General Manager, Growth, Robert Chatwani, reported the acquisition and disposal of company stock and restricted stock units on December 15, 2024.

DocuSign executive Daniel Springer executed multiple transactions involving the company's stock, including sales and option exercises, on December 10, 2024.

DocuSign's CEO, Allan Thygesen, has earned 303,901 performance-based stock units (PSUs) after the company's Compensation Committee certified the achievement of performance criteria related to a 2022 award.

Director Anna Marrs acquired 725 shares of DocuSign common stock through the vesting of restricted stock units on December 4, 2024.

Director Mary Agnes Wilderotter acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Daniel D. Springer acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Anna Marrs acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Teresa Briggs of DocuSign, Inc. reported the acquisition of 1,068 shares of common stock and 1,068 restricted stock units on November 29, 2024.

Director Irving Blake acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director James A. Beer of DocuSign, Inc. reported the acquisition of 1,068 shares of common stock and 1,068 restricted stock units, as well as the disposal of 11,783 shares held indirectly through a trust.

Director Cain A. Hayes acquired 1,068 shares of DocuSign common stock through the vesting of restricted stock units.

Director Peter Solvik of Docusign, Inc. reports the acquisition of 1,068 shares of common stock and 1,068 restricted stock units, along with the disposal of 3,917 shares.

DocuSign's CEO, Allan Thygesen, sold a total of 7,763 shares of common stock on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Docusign director Enrique T. Salem acquired 1,068 shares of common stock through the vesting of restricted stock units.

DocuSign's CEO, Allan Thygesen, sold 7,764 shares of common stock on November 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's CFO, Blake Jeffrey Grayson, sold 9,552 shares of common stock on October 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

James P. Shaughnessy, Chief Legal Officer of DocuSign, sold shares of common stock on October 9, 2024, under a pre-arranged 10b5-1 trading plan.

DocuSign's CEO, Allan Thygesen, sold shares of common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Robert Chatwani, President and General Manager of Growth at DocuSign, sold 14,799 shares of common stock at an average price of $55.46 on September 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

James P. Shaughnessy, Chief Legal Officer of DocuSign, sold 3,600 shares of common stock in two transactions on September 17 and 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold 14,036 shares of common stock on September 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.